{
    "nct_id": "NCT04158635",
    "official_title": "A Phase 1 Study of Gemcitabine, Nab-Paclitaxel, and Bosentan in Patients With Unresectable Pancreatic Cancer",
    "inclusion_criteria": "Main Inclusion Criteria\n\n* Adult patients with unresectable pancreatic carcinoma\n* Patients must be a candidate to receive one of the following chemotherapy combinations as determined by the treating physician:\n\nArm A2: gemcitabine plus nab-paclitaxel given every 2 weeks (arm A1 is closed per this amendment)\n\nArm B: mFOLFIRINOX given every 2 weeks\n\n* Willingness to permit study team to obtain and use archival tissue, if already existing, or, be willing to undergo a fresh tumor biopsy if clinically possible (exceptions may be provided by study PI if medically unsafe to perform biopsy).\n* Weight ≥ 40 kg\n* ANC ≥ 1500/mm3; platelets ≥ 100,000/mm3\n* AST, ALT ≤ 1.5 x ULN. Patients with liver metastases ≤ 3 x ULN\n* Total serum bilirubin ≤ 1.5 x ULN\n* Creatinine clearence ≥ 60 mL/min\n\nMain Exclusion Criteria\n\n* Current or planned use of Warfarin, Cyclosporine A, Rifampicin, Glyburide (other diabetic medications are allowed)\n* Current or planned use of agents contraindicated for use with strong CYP3A4 inducers\n* Strong inhibitors or inducers of CYP2C9\n* Strong inhibitors or inducers of CYP3A\n* Agent or agents that moderately inhibit both CYP2C9 and CYP3A (via a single concomitant agent, or co-administration of concomitant agents)\n* No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated Stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for five years.\n* Current or history of ≥ Grade 2 peripheral neuropathy\n* Known allergy to eggs or any of the components within the study agents and/or their excipients.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}